TABLE III. Cytological diagnosis and human papillomavirus (HPV) infection.
| HPV distribution | Group A (n = 75) n (%) | Group B (n = 76) n (%) | Group C (n = 18) n (%) | |
|---|---|---|---|---|
| HPV DNA prevalence | 35 (20.7) | 9 (11.7) | 8 (10.8) | 18 (100) |
| HPV16 | 21 (60) | 5 (6.5) | 4 (5.4) | 12 (66.7) |
| HPV18 | (25.7) | 0 (0) | 2 (2.7) | 7 (38.9) |
| HPV31 | 11 (31.4) | 1 (1.3) | 3 (4.1) | 7 (38.9) |
| HPV33 | 9 (5.3) | 1 (1.3) | 3 (4.1) | 5 (27.8) |
| HPV39 | 22 (62.8) | 6 (7.8) | 8 (10.8) | 8 (44.4) |
| HPV45 | 3 (8.6) | 1 (1.3) | 0 (0) | 2 (11.1) |
| Multiple HPV infection | 15 (42.8) | 2 (2.6) | 3 (4.1) | 10 (55.6) |
group A: within normal limits; group B: reactive or inflammatory benign cellular changes; group C: atypia or lesions (which included atypical squamous cells of undetermined significance, low-grade squamous intraepithelial lesions, cannot exclude high-grade squamous intraepithelial lesion, and high-grade squamous intraepithelial lesion); HPV: human papillomavirus.